Carriage of the COMT rs4680 polymorphic variant is associated with better tolerance to antipsychotics in adolescents with an acute psychotic episode: a prospective observational clinical study
- Authors: Ivashchenko D.V.1,2, Ivanyuta M.V3, Buromskaya N.I4, Shimanov P.V4, Deitch R.V4, Nastovich M.I4, Akmalova K.A1, Kachanova A.A1, Grishina E.A1, Savchenko L.M1, Shevchenko Y.S1, Sychev D.A1
-
Affiliations:
- Russian Medical Academy of Continuous Professional Education
- Penza Institute for Advanced Medical Education - Branch of the Russian Medical Academy of Continuous Professional Education
- Pirogov Russian National Research Medical University (Pirogov Medical University)
- G.E. Sukhareva Scientific and Practical Center for Mental Health of Children and Adolescents
- Issue: Vol 28, No 3 (2021)
- Pages: 62-67
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/313105
- DOI: https://doi.org/10.18565/pharmateca.2021.3.62-67
- ID: 313105
Cite item
Abstract
Keywords
Full Text
About the authors
Dmitriy V. Ivashchenko
Russian Medical Academy of Continuous Professional Education; Penza Institute for Advanced Medical Education - Branch of the Russian Medical Academy of Continuous Professional Education
Email: dvi1991@yandex.ru
Cand. Sci. (Med.) Moscow, Russia
M. V Ivanyuta
Pirogov Russian National Research Medical University (Pirogov Medical University)Moscow, Russia
N. I Buromskaya
G.E. Sukhareva Scientific and Practical Center for Mental Health of Children and AdolescentsMoscow, Russia
P. V Shimanov
G.E. Sukhareva Scientific and Practical Center for Mental Health of Children and AdolescentsMoscow, Russia
R. V Deitch
G.E. Sukhareva Scientific and Practical Center for Mental Health of Children and AdolescentsMoscow, Russia
M. I Nastovich
G.E. Sukhareva Scientific and Practical Center for Mental Health of Children and AdolescentsMoscow, Russia
K. A Akmalova
Russian Medical Academy of Continuous Professional EducationMoscow, Russia
A. A Kachanova
Russian Medical Academy of Continuous Professional EducationMoscow, Russia
E. A Grishina
Russian Medical Academy of Continuous Professional EducationMoscow, Russia
L. M Savchenko
Russian Medical Academy of Continuous Professional EducationMoscow, Russia
Yu. S Shevchenko
Russian Medical Academy of Continuous Professional EducationMoscow, Russia
D. A Sychev
Russian Medical Academy of Continuous Professional EducationMoscow, Russia
References
- Masi G., Liboni F. Management of schizophrenia in children and adolescents: Focus on pharmacotherapy. Drugs. 2011;71(2):179-208. doi: 10.2165/11585350-000000000-00000.
- McCutcheon R.A., Krystal J.H., Howes O.D. Dopamine and glutamate in schizophrenia: biology, symptoms and treatment. World Psychiatry 2020;19(1):15-33. doi: 10.1002/wps.20693.
- Sagud M., Mück-Seler D., Mihaljevic-Peles A., et al. Catechol-O-methyl transferase and schizophrenia. Psychiatr Danub. 2010;22(2):270-74.
- Huang E., Zai C.C., Lisoway A., et al. Catechol-O-methyltransferase Val158Met polymorphism and clinical response to antipsychotic treatment in schizophrenia and schizo-affective disorder patients: A meta-analysis. int J Neuropsychopharmacol. 2016;19(5):1-12. doi: 10.1093/ijnp/pyv132.
- Qi Z., Miller G.W., Voit E.O. A mathematical model of presynaptic dopamine homeostasis: Implications for schizophrenia. Pharmacopsychiatry. 2008;41(Suppl. 1). doi: 10.1055/s-2008- 1080936.
- Escamilla R., Camarena B., Saracco-Alvarez R., et al. Association study between COMT, DRD2, and DRD3 gene variants and antipsychotic treatment response in Mexican patients with schizophrenia. Neuropsychiatr Dis Treat. 2018;14:2981-87. doi: 10.2147/NDT.S176455.
- Lancaster T.M., Doherty J.L., Linden D.E., Hall J. Imaging Genetics of Schizophrenia. Neuroimaging Genet. Published on-line. 2016:187-208. doi: 10.1093/med/9780199920211.003.0012.
- Perkovic N.M., Sagud M., Zivkovic M., et al. Catechol-O-methyltransferase rs4680 and rs4818 haplotype association with treatment response to olanzapine in patients with schizophrenia. Sci Rep. 2020;10(1). doi: 10.1038/s41598-020-67351-5.
- Hajj A., Obeid S., Sahyoun S., et al. Clinical and genetic factors associated with resistance to treatment in patients with schizophrenia: A case-control study Int J Mol Sci. 2019;20(19):1-17. doi: 10.3390/ijms20194753.
- Eum S., Iee A.M., Bishop J.R. Pharmacogenetic tests for antipsychotic medications: Clinical implications and considerations. Dialog Clin Neurosci. 2016;18(3):323-37. Doi: 10.31887/ dcns.2016.18.3/jbishop.
- Woodward N.D., Jayathilake K., MeltzerH.Y. COMT val108/158met genotype, cognitive function, and cognitive improvement with clozapine in schizophrenia. Schizophr Res. 2007;90(1-3):86-96. doi: 10.1016/j.schres.2006.10.002.
- Bilder R.M., Volavka J., Lachman H.M., Grace A.A. The catechol-O-methyltransferase polymorphism: Relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes. Neuropsychopharmacol. 2004;29(11):1943-61. doi: 10.1038/sj.npp.1300542.
- Dickinson D. Elvevag B. Genes, cognition and brain through a COMT lens. Neurosc. 2009; 164(1):72-87. doi: 10.1016/j.neuroscience. 2009.05.014.
- Opgen-Rhein C., Neuhaus A.H., Urbanek C., et al. Executive Attention in Schizophrenic Males and the Impact of COMT Val108/158Met Genotype on Performance on the Attention Network Test. Schizophr Bull. 2008;34(6):1231-39. doi: 10.1093/schbul/sbm155.
- Bastos P., Gomes T., Ribeiro L. Catechol-O-methyltransferase (COMT): An update on its role in cancer, neurological and cardiovascular diseases. Rev Physiol Biochem Pharmacol. 2017;173:1-39. doi: 10.1007/112_2017_2.
- Magkas N., Tsioufis C., Thomopoulos C., et al. Orthostatic hypotension: From pathophysiology to clinical applications and therapeutic considerations. J Clin Hypertens. 2019;21(5):546-54. doi: 10.1111/jch.13521.
- Ghimire L.V., Kohli U., Li C., et al. Catecholamine pathway gene variation is associated with norepinephrine and epinephrine concentrations at rest and after exercise. Pharmacogenet Genomics. 2012;22(4):254-60. Doi: 10.1097/ FPC.0b013e328350a274.
- Hall K.T. Kossowsky J., Oberlander T.F., et al. Genetic variation in catechol-O-methyltransferase modifies effects of clonidine treatment in chronic fatigue syndrome. Pharmacogenom J. 2016;16(5):454-60. doi: 10.1038/tpj.2016.53.